Stockreport

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report
PDF Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s disease (PD) support P2B001 as a first line, onc [Read more]